Which hedge funds own VOR? VOR BIOPHARMA INC, Q2 2026 13F holders
HealthcareBiotechnologyFollow
32 tracked hedge funds disclosed a position in VOR (VOR BIOPHARMA INC) in their Q2 2026 13F filings, worth $366.5m in total. The largest holder by portfolio weight is NEXTBio Capital Management LP at 7.5% of its book. 10 opened a new position this quarter: Nantahala Capital Management, LLC, ADAR1 Capital Management, LLC, Eversept Partners, LP, EntryPoint Capital, LLC. 7 exited: Propel Bio Management, LLC, Laurion Capital Management LP, Cannon Global Investment Management, LLC.
32
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
10
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
7
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$41.2m
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$13.0m
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$366m
Combined value
Sum of the holders' reported positions in the security.
2.6%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.